ArticleCancer2023

A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies.

Prajwal C Boddu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.